Related Experiment Video
Updated: Sep 13, 2025

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Current insights into breast and ovarian cancer risk: a contemporary review
Natalie A Gaughan1, Nicole Rademacher2, Christine Rogers3
1Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Abstract:
Breast and ovarian cancer account for millions of new cancer diagnoses worldwide annually. An individual's risk of breast and/or ovarian cancer is the result of a complex interplay between non-modifiable and modifiable factors. This review provides a comprehensive map of the current state of our understanding of breast and ovarian cancer risk as conducted through a literature review utilizing PubMed and Cochrane review as primary databases and the selection process prioritized year of publication for up-to-date research and journal impact factor as criteria of research credibility. We review non-modifiable risk factors, such as genetic variations, age, sex assigned at birth, and reproductive history as well as how advances in genetic mapping have led to increased insight in pathogenic germline variants. Additionally, we discuss modifiable factors such as lifestyle and environmental exposures which allow the opportunity for intervention to reduce risk. Contemporary high risk screening tools, including understanding their strengths and weaknesses, are discussed and how they can lend to the determination of eligibility for preventive measures, including risk-reducing operations. The unique challenges of under-represented groups, such as non-Hispanic Black women, transgender/nonbinary/and gender-diverse individuals, and Asian and Pacific Islander populations are reviewed in the context of breast and ovarian cancer risk. Future research on improving risk assessment tools and identifying genomic variants will yield improved personalized healthcare solutions.
Related Concept Videos
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Survival Analysis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell

